In the NAFLD/NASH patients, the frequency of metabolic syndrome is increased and the role of insulin resistance and inflammatory factors has been demonstrated in many studies.3 It has been reported that the D/D allele of the ACE gene shows an increase in serum in insulin resistance and related pathologies.14 This evidence concerns the gene ACE and metabolic dysfunction-associated steatotic liver disease.